Security key
640268108
NEKTAR THERAPEUTICS - Common Stock, $0.0001 par value (NKTR)
CUSIP: 640268108
Q2 2015 13F Holders as of 30 Jun 2015
- Type / Class
- Equity / Common Stock, $0.0001 par value
- Shares outstanding
- 29,109,163
- Total 13F shares
- 138,173,841
- Share change
- +11,843,158
- Total reported value
- $1,728,114,850
- Put/Call ratio
- 83%
- Price per share
- $12.51
- Number of holders
- 177
- Value change
- +$152,141,225
- Number of buys
- 100
- Number of sells
- 67
Report period
Q2 2015
Institutions
177
Top holders
10
NKTR full security history
Newer quarter: Q3 2015
Previous quarter: Q1 2015
NEKTAR THERAPEUTICS SEC filings
NEKTAR THERAPEUTICS company facts
Broader feeds
Reporting periods
Holder history for CUSIP 640268108
Recent filing periods:
Top shareholders of NKTR - NEKTAR THERAPEUTICS - Common Stock, $0.0001 par value (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| OppenheimerFunds, Inc. |
13F
|
Company |
89%
|
26,000,000
|
$286,000,000 | — | 31 Mar 2015 | |
| PRIMECAP MANAGEMENT CO/CA/ |
13F
|
Company |
67%
|
19,552,586
|
$215,078,000 | — | 31 Mar 2015 | |
| VANGUARD GROUP INC |
13F
|
Company |
30%
|
8,742,249
|
$96,165,000 | — | 31 Mar 2015 | |
| FIRST TRUST ADVISORS LP |
13F
|
Company |
22%
|
6,305,115
|
$69,356,000 | — | 31 Mar 2015 | |
| BlackRock Fund Advisors |
13F
|
Company |
17%
|
4,869,231
|
$53,562,000 | — | 31 Mar 2015 | |
| STATE STREET CORP |
13F
|
Company |
17%
|
4,809,266
|
$52,905,000 | — | 31 Mar 2015 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
16%
|
4,546,714
|
$50,013,000 | — | 31 Mar 2015 | |
| BlackRock Institutional Trust Company, N.A. |
13F
|
Company |
15%
|
4,365,679
|
$48,022,000 | — | 31 Mar 2015 | |
| FEDERATED HERMES, INC. |
13F
|
Company |
15%
|
4,249,572
|
$46,745,000 | — | 31 Mar 2015 | |
| Invesco Ltd. |
13F
|
Company |
13%
|
3,642,734
|
$40,070,000 | — | 31 Mar 2015 | |
| Bank of New York Mellon Corp |
13F
|
Company |
8.5%
|
2,474,405
|
$27,218,000 | — | 31 Mar 2015 | |
| Granahan Investment Management, LLC |
13F
|
Company |
7.6%
|
2,216,945
|
$24,386,000 | — | 31 Mar 2015 | |
| NORGES BANK |
13F
|
Company |
7.3%
|
2,134,205
|
$23,476,000 | — | 31 Mar 2015 | |
| FMR LLC |
13F
|
Company |
5.9%
|
1,709,803
|
$18,808,000 | — | 31 Mar 2015 | |
| Artal Group S.A. |
13F
|
Company |
5.8%
|
1,700,000
|
$18,700,000 | — | 31 Mar 2015 | |
| JANUS HENDERSON INVESTORS US LLC |
13F
|
Company |
5.1%
|
1,488,524
|
$16,374,000 | — | 31 Mar 2015 | |
| NORTHERN TRUST CORP |
13F
|
Company |
4.9%
|
1,429,074
|
$15,720,000 | — | 31 Mar 2015 | |
| VOYA INVESTMENT MANAGEMENT LLC |
13F
|
Company |
4.4%
|
1,268,997
|
$13,959,000 | — | 31 Mar 2015 | |
| PANAGORA ASSET MANAGEMENT INC |
13F
|
Company |
3.8%
|
1,099,348
|
$12,093,000 | — | 31 Mar 2015 | |
| SYSTEMATIC FINANCIAL MANAGEMENT LP |
13F
|
Company |
3.7%
|
1,089,075
|
$11,979,000 | — | 31 Mar 2015 | |
| Rhenman & Partners Asset Management AB |
13F
|
Company |
3.4%
|
996,600
|
$10,963,000 | — | 31 Mar 2015 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
2.9%
|
848,485
|
$9,333,000 | — | 31 Mar 2015 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
2.8%
|
814,258
|
$8,956,000 | — | 31 Mar 2015 | |
| Allianz Asset Management GmbH |
13F
|
Company |
2.7%
|
772,309
|
$8,495,000 | — | 31 Mar 2015 | |
| D. E. Shaw & Co., Inc. |
13F
|
Company |
2.6%
|
748,678
|
$8,236,000 | — | 31 Mar 2015 | |
| TIAA CREF INVESTMENT MANAGEMENT LLC |
13F
|
Company |
2.5%
|
724,126
|
$7,965,000 | — | 31 Mar 2015 | |
| TIRSCHWELL & LOEWY INC |
13F
|
Company |
2.4%
|
692,441
|
$7,617,000 | — | 31 Mar 2015 | |
| Duquesne Family Office LLC |
13F
|
Company |
2.3%
|
655,000
|
$7,205,000 | — | 31 Mar 2015 | |
| Artisan Partners Limited Partnership |
13F
|
Company |
2.1%
|
607,868
|
$6,687,000 | — | 31 Mar 2015 | |
| PointState Capital LP |
13F
|
Company |
2.1%
|
600,000
|
$6,600,000 | — | 31 Mar 2015 | |
| Cheyne Capital Management (UK) LLP |
13F
|
Company |
2%
|
589,260
|
$6,479,000 | — | 31 Mar 2015 | |
| EAGLE ASSET MANAGEMENT INC |
13F
|
Company |
2%
|
586,709
|
$6,453,000 | — | 31 Mar 2015 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
2%
|
568,048
|
$6,249,000 | — | 31 Mar 2015 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
1.9%
|
566,286
|
$6,229,000 | — | 31 Mar 2015 | |
| MORGAN STANLEY |
13F
|
Company |
1.9%
|
556,435
|
$6,121,000 | — | 31 Mar 2015 | |
| RICE HALL JAMES & ASSOCIATES, LLC |
13F
|
Company |
1.8%
|
527,575
|
$5,803,000 | — | 31 Mar 2015 | |
| ALLIANCEBERNSTEIN L.P. |
13F
|
Company |
1.7%
|
508,747
|
$5,596,000 | — | 31 Mar 2015 | |
| ALTRINSIC GLOBAL ADVISORS LLC |
13F
|
Company |
1.6%
|
460,000
|
$5,060,000 | — | 31 Mar 2015 | |
| CREDIT SUISSE AG/ |
13F
|
Company |
1.6%
|
456,490
|
$5,021,000 | — | 31 Mar 2015 | |
| DEUTSCHE BANK AG\ |
13F
|
Company |
1.5%
|
439,924
|
$4,837,000 | — | 31 Mar 2015 | |
| GUGGENHEIM CAPITAL LLC |
13F
|
Company |
1.4%
|
418,200
|
$4,600,000 | — | 31 Mar 2015 | |
| Cormorant Asset Management, LP |
13F
|
Company |
1.4%
|
397,500
|
$4,373,000 | — | 31 Mar 2015 | |
| PRICE T ROWE ASSOCIATES INC /MD/ |
13F
|
Company |
1.3%
|
374,100
|
$4,115,000 | — | 31 Mar 2015 | |
| BlackRock Investment Management, LLC |
13F
|
Company |
1.3%
|
373,919
|
$4,113,000 | — | 31 Mar 2015 | |
| ArrowMark Colorado Holdings LLC |
13F
|
Company |
1.3%
|
364,905
|
$4,014,000 | — | 31 Mar 2015 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
1.2%
|
359,183
|
$3,952,000 | — | 31 Mar 2015 | |
| Opus Point Partners Management, LLC |
13F
|
Company |
1.2%
|
335,650
|
$3,692,000 | — | 31 Mar 2015 | |
| S.c.a. Candriam |
13F
|
Individual |
1.1%
|
320,000
|
$3,521,000 | — | 31 Mar 2015 | |
| HARVEY CAPITAL MANAGEMENT INC |
13F
|
Company |
1.1%
|
313,800
|
$3,451,000 | — | 31 Mar 2015 | |
| PRINCIPAL FINANCIAL GROUP INC |
13F
|
Company |
1%
|
290,949
|
$3,200,000 | — | 31 Mar 2015 |
Institutional Holders of NEKTAR THERAPEUTICS - Common Stock, $0.0001 par value (NKTR) as of Q2 2015
As of 30 Jun 2015,
NEKTAR THERAPEUTICS - Common Stock, $0.0001 par value (NKTR) was held by
177 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
138,173,841 shares.
The largest 10 holders included
OPPENHEIMER FUNDS INC, PRIMECAP MANAGEMENT CO/CA/, VANGUARD GROUP INC, FIRST TRUST ADVISORS LP, BlackRock Fund Advisors, STATE STREET CORP, Invesco Ltd., FEDERATED INVESTORS INC /PA/, BlackRock Institutional Trust Company, N.A., and GRANAHAN INVESTMENT MANAGEMENT INC/MA.
This page lists
177
institutional shareholders reporting positions in this security
for the Q2 2015 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2015 vs Q1 2015 Across Filers
Q1 2015 holders
152
Q2 2015 holders
177
Holder diff
25
| Investor | Q1 2015 Shares | Q2 2015 Shares | Share Diff | Share Chg % | Q1 2015 Value $ | Q2 2015 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.